by mediaid pharmacy | Feb 3, 2026 | Uncategorized
Osimert 80 mg has emerged as a groundbreaking targeted therapy for patients diagnosed with epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). As a third-generation tyrosine kinase inhibitor, Osimertinib offers hope to...
by mediaid pharmacy | Feb 2, 2026 | Blogs
Ibruxen 140 mg (Ibrutinib) | Uses, Price & Safety Ibruxen 140 mg is an oral targeted cancer therapy containing ibrutinib, a Bruton’s Tyrosine Kinase (BTK) inhibitor widely used in modern hematology-oncology. This medicine is prescribed for certain blood...
by mediaid pharmacy | Feb 1, 2026 | Blogs
Ponaxen 15mg & 45mg (Ponatinib): Complete Guide, Uses, Dosage & Best Price Ponaxen 15mg & 45mg (Ponatinib) is a clinically proven tyrosine kinase inhibitor (TKI) used in the treatment of resistant or intolerant forms of leukemia, especially Chronic Myeloid...
by mediaid pharmacy | Jan 31, 2026 | Blogs
Lenvaxen 4 mg and 10 mg (Lenvatinib) | Complete Guide to Dosage, Price & Availability Lenvaxen 4 mg and 10 mg is a targeted therapy medication containing Lenvatinib, a multi-kinase inhibitor used in the treatment of various cancers. This comprehensive guide...
by mediaid pharmacy | Jan 29, 2026 | Blogs
Laronib 25mg & 100mg (Larotrectinib) is a precision oncology medicine used for the treatment of cancers driven by NTRK gene fusions. This blog provides an expert, authoritative, and trustworthy overview of Laronib capsules, covering indications, dosage strengths,...
